CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF CHILDREN WITH COVID-19 DUE TO CYSTIC FIBROSIS
Keywords:
cystic fibrosis, COVID-19, cytokine, immunology.Abstract
The study of clinical and immunological characteristics of children with COVID-19 against the background of cystic fibrosis is becoming highly relevant in light of the pandemic. Cystic fibrosis, as a chronic disease, poses special challenges to the immune system, which makes patients in this group vulnerable to the SARS-CoV-2 virus.
References
Bodas M, Vij N. Adapting proteostasis and autophagy for controlling the pathogenesis of cystic fibrosis lung disease. Front Pharm. 2019;10:20.
Colombo C, Burgel PR, Gartner S, van Koningsbruggen-Rietschel S, Naehrlich L, Sermet-Gaudelus I, et al. Impact of COVID-19 on people with cystic fibrosis. Lancet Respir Med. 2020;8:e35–e36.
Cosgriff R, Ahern S, Bell SC, Brownlee K, Burgel PR, Byrnes C, et al. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis. J Cyst Fibros. 2020. https://doi.org/10.1016/j.jcf.2020.04.012.
Flight WG, Bright-Thomas RJ, Tilston P, Mutton KJ, Guiver M, Morris J, et al. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax. 2014;69:247–53.
Ornatowski W, Poschet JF, Perkett E, Taylor-Cousar JL, Deretic V. Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity. J Clin Invest. 2007;117:3489–97.
Poli P, Timpano S, Goffredo M, Padoan R, Badolato R. Asymptomatic case of Covid-19 in an infant with cystic fibrosis. J Cyst Fibros. 2020. https://doi.org/10.1016/j.jcf.2020.03.017.
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.